Secretary Kennedy’s reductions in force, offered as reform, may cripple drug approvals, gut biomedical research, and gamble ...

July marks a transformative month in oncology with the FDA's groundbreaking approvals and updates, enhancing treatment ...

Artificial Intelligence (AI) continues to revolutionize industries and is poised to bring transformative change in healthcare delivery, ...

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more ...

A secretive AI tool is already in motion, raising alarm among experts who warn of serious risks as it reshapes how the ...

Dr. Vinay Prasad, a vocal critic of the FDA before joining its ranks, has stepped down from his leadership post at the agency ...

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking ...

Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

"This was primarily driven by 18% growth seen from the oncology portfolio, which has done well as a result of key drugs such ...

Reduce development timelines and costs, while improving access to life-saving treatments VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfur ...